Domestic News: New Products, Technological Innovations, and M&A
1. Philips Launches "Verida," the World's First AI-Powered Multi-Energy Spectral CT
News Highlights
Philips Japan announced the launch of "Verida," the world's first detector-based multi-energy spectral CT, which integrates AI into the entire image acquisition process, from CT scanning to image reconstruction. Sales are scheduled to begin on April 17, 2026.
Impact on the Industry
This technology enables the simultaneous acquisition of high-definition conventional images and rich spectral information from a single scan, using the same workflow as conventional CT examinations. Image reconstruction after examination is also accelerated to a maximum of 145 frames per second, which is expected to significantly improve examination throughput in radiology departments and reduce the workload of medical professionals.
2. Philips Announces New "BlueSeal" Series of Next-Generation Helium-Free MRI
News Highlights
Philips Japan announced the new "BlueSeal" series of MRI systems, which feature "Micro-cooling technology" that seals and circulates only 7 liters of liquid helium (less than 0.5% of conventional systems).
Impact on the Industry
Eliminating the need for continuous helium replenishment allows for rapid recovery in the event of disasters or unexpected emergencies. Furthermore, the integration of the Dual AI engine "SmartSpeed Precise" simultaneously achieves up to a 67% reduction in imaging time and up to an 80% increase in image resolution. This innovative solution is noteworthy for supporting both the provision of a sustainable and stable examination environment and the improvement of profitability.
3. Asahi Intecc Concludes Exclusive Distribution Agreement in Japan for Korean Company's Embolic Agent "Nexsphere-F"
News Highlights
Asahi Intecc Co., Ltd. has entered into an exclusive distribution agreement in the Japanese market for "Nexsphere-F," an embolic agent developed and manufactured by NEXTBIOMEDICAL, a South Korean medical device company.
Impact on the Industry
"Nexsphere-F" is a temporary embolic agent used in TAME therapy (Transcatheter Arterial Microembolization) to deliver embolic material to abnormal blood vessels that cause chronic pain. Although it is not yet approved for medical use in Japan, the company aims to have it covered by health insurance after approval, and it is anticipated to be a new treatment option that will contribute to improving the QOL (Quality of Life) of chronic pain patients.
International News: Regulatory Trends, New Products, and Market Environment
1. US FDA and Medtech Industry Reach General Agreement on Medical Device User Fee Amendments (MDUFA VI)
News Highlights
The U.S. Food and Drug Administration (FDA) and the medical device industry have reached an "agreement in principle" on the 6th Medical Device User Fee Amendments (MDUFA VI), which will be effective from 2027 to 2032.
Impact on the Industry
A significant increase in review staff has been promised to address chronic staffing shortages. Furthermore, a restructuring of the fee system based on an "America First" approach has been proposed, with facility registration fees for foreign companies expected to increase, while application and registration costs for many domestic (U.S.) companies are projected to decrease from fiscal year 2028.
2. Stereotaxis Receives FDA Approval for "Synchrony" Endovascular Robotic System
News Highlights
Stereotaxis, a pioneer in robotic surgical systems for minimally invasive endovascular interventions, announced that it has received FDA 510(k) clearance for its new "Synchrony" system, which digitalizes and modernizes catheterization labs.
Industry Impact
"Synchrony" is a system that consolidates and displays all system images and controls within the catheterization lab on a 55-inch 4K ultra-high-definition display with ultra-low latency. Its integration with the cloud-based application "SynX" enables secure remote connectivity and monitoring, and it is anticipated to serve as a foundational technology for future AI applications and remote robotic surgery.
3. J&J's Intraocular Lens "TECNIS Eyhance" Exceeds 10 Million Implantations Worldwide
News Highlights
Johnson & Johnson MedTech announced that "TECNIS Eyhance," the industry's first extended depth of focus (EDOF) monofocal intraocular lens (IOL), has achieved over 10 million implantations worldwide since its launch in 2019.
Industry Impact
"TECNIS Eyhance" is characterized by a design that slightly extends the depth of focus to improve intermediate vision while maintaining comparable distance vision and image contrast to a standard monofocal lens. It has solidified its position as a standard option in cataract surgery, enhancing patients' quality of life.
Summary: Key Industry Trends
From today's news, it is evident that the medical device industry is currently moving along the following three major trends:
- Full integration of AI technology and transformation of workflows (e.g., Philips' AI-powered CT "Verida" and MRI "BlueSeal," implementing AI across all processes from diagnosis to reconstruction)
- Pursuit of sustainability and resilience (e.g., widespread adoption of helium-free MRI, optimization of supply chains)
- Digitalization of operating rooms and catheterization labs, and establishment of remote medical infrastructure (e.g., Stereotaxis' "Synchrony" system)
In particular, the implementation of AI in the field of diagnostic imaging has evolved from "partial assistance" to "integration into the entire system," becoming a powerful driving force for simultaneously resolving labor shortages in healthcare settings and improving diagnostic accuracy.
Related Links
- PR TIMES: Philips Launches Verida, the World's First AI-Powered Multi-Energy Spectral CT
- PR TIMES: Introducing BlueSeal, a New Series Offering New Clinical Value with Next-Generation Helium-Free Magnets x AI Solutions
- Zaikei Shimbun: Asahi Intecc Concludes Exclusive Japan Distribution Agreement for Embolic Agent "Nexsphere-F"
- HealthEconomics.com: FDA and Medtech Industry Reach Preliminary MDUFA VI Agreement
- GlobeNewswire: Stereotaxis Announces FDA Clearance and Launch of Synchrony System
- Johnson & Johnson MedTech: TECNIS Eyhance IOL Surpasses 10 Million Global Implants
Need help with Japan's medical device approval?
Our regulatory affairs consultants specializing in digestive endoscopy devices provide end-to-end support from strategy to document preparation. Contact us for a free initial consultation.
Free Consultation